What is the primary concern for a patient taking ASA?

The primary concern for a patient taking ASA (Acetylsalicylic Acid, commonly known as aspirin) relates to excess bleeding. Aspirin acts as an antiplatelet medication, which means it inhibits the aggregation of platelets in the blood. While this is beneficial in reducing the risk of blood clots and preventing cardiovascular events, it also means that patients on aspirin are at a heightened risk of bleeding complications. This can manifest as gastrointestinal bleeding or bruising more easily due to the inhibition of the clotting process.

In this context, other options such as increased risk of infection, elevated blood pressure, and kidney damage, while potentially relevant in broader healthcare discussions, are not the primary concerns directly associated with ASA use. The antiplatelet effect of aspirin is the most significant aspect to monitor, making awareness of bleeding risks essential for patient safety.